Market Overview
The global Sickle Cell Disease Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Sickle Cell Disease Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Sickle Cell Disease Drug market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Sickle Cell Disease Drug market has been segmented into ARQ-092, BIVV-003, CAL-H, CTX-001, DRX-194, Others, etc.
Breakdown by Application, Sickle Cell Disease Drug has been segmented into Hospital, Clinic, Others, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sickle Cell Disease Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Sickle Cell Disease Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sickle Cell Disease Drug market.
For Japan, this report analyses the Japan market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Sickle Cell Disease Drug Market Share Analysis
Sickle Cell Disease Drug competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Sickle Cell Disease Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sickle Cell Disease Drug sales, revenue and market share for each player covered in this report.
The major players covered in Sickle Cell Disease Drug are: Acceleron Pharma Inc, bluebird bio Inc, Annexin Pharmaceuticals AB, Addmedica SAS, Bioverativ Inc, Angiocrine Bioscience Inc, Calimmune Inc, Bio Products Laboratory Ltd, ArQule Inc, Bristol-Myers Squibb Co, Errant Gene Therapeutics LLC, Gilead Sciences Inc, CRISPR Therapeutics, Gamida Cell Ltd, Editas Medicine Inc, CSL Ltd, Global Blood Therapeutics Inc, Genethon SA, Daiichi Sankyo Co Ltd, etc. Among other players domestic and global, Sickle Cell Disease Drug market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Sickle Cell Disease Drug market are listed below:
Acceleron Pharma Inc
bluebird bio Inc
Annexin Pharmaceuticals AB
Addmedica SAS
Bioverativ Inc
Angiocrine Bioscience Inc
Calimmune Inc
Bio Products Laboratory Ltd
ArQule Inc
Bristol-Myers Squibb Co
Errant Gene Therapeutics LLC
Gilead Sciences Inc
CRISPR Therapeutics
Gamida Cell Ltd
Editas Medicine Inc
CSL Ltd
Global Blood Therapeutics Inc
Genethon SA
Daiichi Sankyo Co Ltd
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
ARQ-092
BIVV-003
CAL-H
CTX-001
DRX-194
Others
Market segment by Application, can be divided into
Hospital
Clinic
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Sickle Cell Disease Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Sickle Cell Disease Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ARQ-092
1.2.3 BIVV-003
1.2.4 CAL-H
1.2.5 CTX-001
1.2.6 DRX-194
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Sickle Cell Disease Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
1.4.1 Global Sickle Cell Disease Drug Revenue and Forecast (2015-2025)
1.4.2 Global Sickle Cell Disease Drug Sales and Forecast (2015-2025)
1.5 Global Sickle Cell Disease Drug Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Acceleron Pharma Inc
2.1.1 Acceleron Pharma Inc Details
2.1.2 Acceleron Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Acceleron Pharma Inc SWOT Analysis
2.1.4 Acceleron Pharma Inc Product and Services
2.1.5 Acceleron Pharma Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 bluebird bio Inc
2.2.1 bluebird bio Inc Details
2.2.2 bluebird bio Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 bluebird bio Inc SWOT Analysis
2.2.4 bluebird bio Inc Product and Services
2.2.5 bluebird bio Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Annexin Pharmaceuticals AB
2.3.1 Annexin Pharmaceuticals AB Details
2.3.2 Annexin Pharmaceuticals AB Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Annexin Pharmaceuticals AB SWOT Analysis
2.3.4 Annexin Pharmaceuticals AB Product and Services
2.3.5 Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Addmedica SAS
2.4.1 Addmedica SAS Details
2.4.2 Addmedica SAS Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Addmedica SAS SWOT Analysis
2.4.4 Addmedica SAS Product and Services
2.4.5 Addmedica SAS Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bioverativ Inc
2.5.1 Bioverativ Inc Details
2.5.2 Bioverativ Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Bioverativ Inc SWOT Analysis
2.5.4 Bioverativ Inc Product and Services
2.5.5 Bioverativ Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Angiocrine Bioscience Inc
2.6.1 Angiocrine Bioscience Inc Details
2.6.2 Angiocrine Bioscience Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Angiocrine Bioscience Inc SWOT Analysis
2.6.4 Angiocrine Bioscience Inc Product and Services
2.6.5 Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Calimmune Inc
2.7.1 Calimmune Inc Details
2.7.2 Calimmune Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Calimmune Inc SWOT Analysis
2.7.4 Calimmune Inc Product and Services
2.7.5 Calimmune Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Bio Products Laboratory Ltd
2.8.1 Bio Products Laboratory Ltd Details
2.8.2 Bio Products Laboratory Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Bio Products Laboratory Ltd SWOT Analysis
2.8.4 Bio Products Laboratory Ltd Product and Services
2.8.5 Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 ArQule Inc
2.9.1 ArQule Inc Details
2.9.2 ArQule Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 ArQule Inc SWOT Analysis
2.9.4 ArQule Inc Product and Services
2.9.5 ArQule Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bristol-Myers Squibb Co
2.10.1 Bristol-Myers Squibb Co Details
2.10.2 Bristol-Myers Squibb Co Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bristol-Myers Squibb Co SWOT Analysis
2.10.4 Bristol-Myers Squibb Co Product and Services
2.10.5 Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Errant Gene Therapeutics LLC
2.11.1 Errant Gene Therapeutics LLC Details
2.11.2 Errant Gene Therapeutics LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Errant Gene Therapeutics LLC SWOT Analysis
2.11.4 Errant Gene Therapeutics LLC Product and Services
2.11.5 Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Gilead Sciences Inc
2.12.1 Gilead Sciences Inc Details
2.12.2 Gilead Sciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Gilead Sciences Inc SWOT Analysis
2.12.4 Gilead Sciences Inc Product and Services
2.12.5 Gilead Sciences Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 CRISPR Therapeutics
2.13.1 CRISPR Therapeutics Details
2.13.2 CRISPR Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 CRISPR Therapeutics SWOT Analysis
2.13.4 CRISPR Therapeutics Product and Services
2.13.5 CRISPR Therapeutics Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Gamida Cell Ltd
2.14.1 Gamida Cell Ltd Details
2.14.2 Gamida Cell Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Gamida Cell Ltd SWOT Analysis
2.14.4 Gamida Cell Ltd Product and Services
2.14.5 Gamida Cell Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Editas Medicine Inc
2.15.1 Editas Medicine Inc Details
2.15.2 Editas Medicine Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Editas Medicine Inc SWOT Analysis
2.15.4 Editas Medicine Inc Product and Services
2.15.5 Editas Medicine Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 CSL Ltd
2.16.1 CSL Ltd Details
2.16.2 CSL Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 CSL Ltd SWOT Analysis
2.16.4 CSL Ltd Product and Services
2.16.5 CSL Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Global Blood Therapeutics Inc
2.17.1 Global Blood Therapeutics Inc Details
2.17.2 Global Blood Therapeutics Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Global Blood Therapeutics Inc SWOT Analysis
2.17.4 Global Blood Therapeutics Inc Product and Services
2.17.5 Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.18 Genethon SA
2.18.1 Genethon SA Details
2.18.2 Genethon SA Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 Genethon SA SWOT Analysis
2.18.4 Genethon SA Product and Services
2.18.5 Genethon SA Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.19 Daiichi Sankyo Co Ltd
2.19.1 Daiichi Sankyo Co Ltd Details
2.19.2 Daiichi Sankyo Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Daiichi Sankyo Co Ltd SWOT Analysis
2.19.4 Daiichi Sankyo Co Ltd Product and Services
2.19.5 Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Sickle Cell Disease Drug Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Sickle Cell Disease Drug Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Sickle Cell Disease Drug Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: Japan
3.2.1 Key Players Sickle Cell Disease Drug Sales in Japan (2018-2019)
3.2.2 Japan Sickle Cell Disease Drug Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Sickle Cell Disease Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Sickle Cell Disease Drug Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Sickle Cell Disease Drug Market Size by Geography (2015-2020)
4.1.1 Global Sickle Cell Disease Drug Sales by Geography (2015-2020)
4.1.2 Global Sickle Cell Disease Drug Revenue by Regions (2015-2020)
4.2 Global Sickle Cell Disease Drug Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Sickle Cell Disease Drug Sales and Forecast by Regions (2020-2025)
4.2.2 Global Sickle Cell Disease Drug Revenue and Forecast by Regions (2020-2025)
4.3 North America Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
4.4 Europe Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
4.6 South America Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Sickle Cell Disease Drug Market Size by Country (2015-2020)
5.1.1 North America Sickle Cell Disease Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Sickle Cell Disease Drug Revenue and Market Share by Country (2015-2020)
5.2 North America Sickle Cell Disease Drug Market Size and Forecast by Country (2020-2025)
5.2.1 North America Sickle Cell Disease Drug Sales and Forecast by Country (2020-2025)
5.2.2 North America Sickle Cell Disease Drug Revenue and Forecast by Country (2020-2025)
5.3 United States Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
5.4 Canada Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
5.5 Mexico Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Sickle Cell Disease Drug Market Size by Country (2015-2020)
6.1.1 Europe Sickle Cell Disease Drug Sales by Country (2015-2020)
6.1.2 Europe Sickle Cell Disease Drug Revenue by Country (2015-2020)
6.2 Europe Sickle Cell Disease Drug Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Sickle Cell Disease Drug Sales and Forecast by Country (2020-2025)
6.2.2 Europe Sickle Cell Disease Drug Revenue and Forecast by Country (2020-2025)
6.3 Germany Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
6.4 United Kingdom Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
6.5 France Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
6.6 Russia Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
6.7 Italy Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Sickle Cell Disease Drug Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Sickle Cell Disease Drug Sales by Region (2015-2020)
7.1.2 Asia-Pacific Sickle Cell Disease Drug Revenue by Region (2015-2020)
7.2 Asia-Pacific Sickle Cell Disease Drug Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Sickle Cell Disease Drug Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Sickle Cell Disease Drug Revenue and Forecast by Region (2020-2025)
7.3 China Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
7.4 Japan Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
7.5 Korea Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
7.6 India Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
7.7 Southeast Asia Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
7.8 Australia Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Sickle Cell Disease Drug Market Size by Country (2015-2020)
8.1.1 South America Sickle Cell Disease Drug Sales by Country (2015-2020)
8.1.2 South America Sickle Cell Disease Drug Revenue by Country (2015-2020)
8.2 South America Sickle Cell Disease Drug Market Size and Forecast by Country (2020-2025)
8.2.1 South America Sickle Cell Disease Drug Sales and Forecast by Country (2020-2025)
8.2.2 South America Sickle Cell Disease Drug Revenue and Forecast by Country (2020-2025)
8.3 Brazil Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
8.4 Argentina Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Sickle Cell Disease Drug Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Sickle Cell Disease Drug Sales by Country (2015-2020)
9.1.2 Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2015-2020)
9.2 Middle East & Africa Sickle Cell Disease Drug Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Sickle Cell Disease Drug Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Sickle Cell Disease Drug Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
9.4 Turkey Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
9.5 Egypt Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
9.6 South Africa Sickle Cell Disease Drug Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Sickle Cell Disease Drug Market Size by Type (2015-2020)
10.1.1 Global Sickle Cell Disease Drug Sales by Type (2015-2020)
10.1.2 Global Sickle Cell Disease Drug Revenue by Type (2015-2020)
10.1.3 Global Sickle Cell Disease Drug Price by Type (2015-2020)
10.2 Global Sickle Cell Disease Drug Market Size and Forecast by Type (2020-2025)
10.2.1 Global Sickle Cell Disease Drug Sales and Forecast by Type (2020-2025)
10.2.2 Global Sickle Cell Disease Drug Revenue and Forecast by Type (2020-2025)
10.2.3 Global Sickle Cell Disease Drug Price and Forecast by Type (2020-2025)
10.3 Japan Sickle Cell Disease Drug Market Size and Forecast by Type (2015-2025)
10.3.1 Japan Sickle Cell Disease Drug Market Size by Type (2015-2020)
10.3.2 Japan Sickle Cell Disease Drug Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Sickle Cell Disease Drug Market Size by Application (2015-2020)
11.1.1 Global Sickle Cell Disease Drug Sales by Application (2015-2020)
11.1.2 Global Sickle Cell Disease Drug Revenue by Application (2015-2020)
11.1.3 Global Sickle Cell Disease Drug Price by Application (2015-2020)
11.2 Global Sickle Cell Disease Drug Market Size and Forecast by Application (2020-2025)
11.2.1 Global Sickle Cell Disease Drug Sales and Forecast by Application (2020-2025)
11.2.2 Global Sickle Cell Disease Drug Revenue and Forecast by Application (2020-2025)
11.2.3 Global Sickle Cell Disease Drug Price and Forecast by Application (2020-2025)
11.3 Japan Sickle Cell Disease Drug Market Size and Forecast by Application (2015-2025)
11.3.1 Japan Sickle Cell Disease Drug Market Size by Application (2015-2020)
11.3.2 Japan Sickle Cell Disease Drug Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
List of Tables
Table 1. Global Sickle Cell Disease Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sickle Cell Disease Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sickle Cell Disease Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Sickle Cell Disease Drug Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Acceleron Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 6. Acceleron Pharma Inc Sickle Cell Disease Drug Major Business
Table 7. Acceleron Pharma Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 8. Acceleron Pharma Inc SWOT Analysis
Table 9. Acceleron Pharma Inc Sickle Cell Disease Drug Product and Services
Table 10. Acceleron Pharma Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. bluebird bio Inc Basic Information, Manufacturing Base and Competitors
Table 12. bluebird bio Inc Sickle Cell Disease Drug Major Business
Table 13. bluebird bio Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 14. bluebird bio Inc SWOT Analysis
Table 15. bluebird bio Inc Sickle Cell Disease Drug Product and Services
Table 16. bluebird bio Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Annexin Pharmaceuticals AB Basic Information, Manufacturing Base and Competitors
Table 18. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Major Business
Table 19. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 20. Annexin Pharmaceuticals AB SWOT Analysis
Table 21. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Product and Services
Table 22. Annexin Pharmaceuticals AB Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. Addmedica SAS Basic Information, Manufacturing Base and Competitors
Table 24. Addmedica SAS Sickle Cell Disease Drug Major Business
Table 25. Addmedica SAS Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 26. Addmedica SAS SWOT Analysis
Table 27. Addmedica SAS Sickle Cell Disease Drug Product and Services
Table 28. Addmedica SAS Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Bioverativ Inc Basic Information, Manufacturing Base and Competitors
Table 30. Bioverativ Inc Sickle Cell Disease Drug Major Business
Table 31. Bioverativ Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 32. Bioverativ Inc SWOT Analysis
Table 33. Bioverativ Inc Sickle Cell Disease Drug Product and Services
Table 34. Bioverativ Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Angiocrine Bioscience Inc Basic Information, Manufacturing Base and Competitors
Table 36. Angiocrine Bioscience Inc Sickle Cell Disease Drug Major Business
Table 37. Angiocrine Bioscience Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 38. Angiocrine Bioscience Inc SWOT Analysis
Table 39. Angiocrine Bioscience Inc Sickle Cell Disease Drug Product and Services
Table 40. Angiocrine Bioscience Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Calimmune Inc Basic Information, Manufacturing Base and Competitors
Table 42. Calimmune Inc Sickle Cell Disease Drug Major Business
Table 43. Calimmune Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 44. Calimmune Inc SWOT Analysis
Table 45. Calimmune Inc Sickle Cell Disease Drug Product and Services
Table 46. Calimmune Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Bio Products Laboratory Ltd Basic Information, Manufacturing Base and Competitors
Table 48. Bio Products Laboratory Ltd Sickle Cell Disease Drug Major Business
Table 49. Bio Products Laboratory Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 50. Bio Products Laboratory Ltd SWOT Analysis
Table 51. Bio Products Laboratory Ltd Sickle Cell Disease Drug Product and Services
Table 52. Bio Products Laboratory Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. ArQule Inc Basic Information, Manufacturing Base and Competitors
Table 54. ArQule Inc Sickle Cell Disease Drug Major Business
Table 55. ArQule Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 56. ArQule Inc SWOT Analysis
Table 57. ArQule Inc Sickle Cell Disease Drug Product and Services
Table 58. ArQule Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Bristol-Myers Squibb Co Basic Information, Manufacturing Base and Competitors
Table 60. Bristol-Myers Squibb Co Sickle Cell Disease Drug Major Business
Table 61. Bristol-Myers Squibb Co Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 62. Bristol-Myers Squibb Co SWOT Analysis
Table 63. Bristol-Myers Squibb Co Sickle Cell Disease Drug Product and Services
Table 64. Bristol-Myers Squibb Co Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. Errant Gene Therapeutics LLC Basic Information, Manufacturing Base and Competitors
Table 66. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Major Business
Table 67. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 68. Errant Gene Therapeutics LLC SWOT Analysis
Table 69. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Product and Services
Table 70. Errant Gene Therapeutics LLC Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Gilead Sciences Inc Basic Information, Manufacturing Base and Competitors
Table 72. Gilead Sciences Inc Sickle Cell Disease Drug Major Business
Table 73. Gilead Sciences Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 74. Gilead Sciences Inc SWOT Analysis
Table 75. Gilead Sciences Inc Sickle Cell Disease Drug Product and Services
Table 76. Gilead Sciences Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. CRISPR Therapeutics Basic Information, Manufacturing Base and Competitors
Table 78. CRISPR Therapeutics Sickle Cell Disease Drug Major Business
Table 79. CRISPR Therapeutics Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 80. CRISPR Therapeutics SWOT Analysis
Table 81. CRISPR Therapeutics Sickle Cell Disease Drug Product and Services
Table 82. CRISPR Therapeutics Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. Gamida Cell Ltd Basic Information, Manufacturing Base and Competitors
Table 84. Gamida Cell Ltd Sickle Cell Disease Drug Major Business
Table 85. Gamida Cell Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 86. Gamida Cell Ltd SWOT Analysis
Table 87. Gamida Cell Ltd Sickle Cell Disease Drug Product and Services
Table 88. Gamida Cell Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Editas Medicine Inc Basic Information, Manufacturing Base and Competitors
Table 90. Editas Medicine Inc Sickle Cell Disease Drug Major Business
Table 91. Editas Medicine Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 92. Editas Medicine Inc SWOT Analysis
Table 93. Editas Medicine Inc Sickle Cell Disease Drug Product and Services
Table 94. Editas Medicine Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. CSL Ltd Basic Information, Manufacturing Base and Competitors
Table 96. CSL Ltd Sickle Cell Disease Drug Major Business
Table 97. CSL Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 98. CSL Ltd SWOT Analysis
Table 99. CSL Ltd Sickle Cell Disease Drug Product and Services
Table 100. CSL Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Global Blood Therapeutics Inc Basic Information, Manufacturing Base and Competitors
Table 102. Global Blood Therapeutics Inc Sickle Cell Disease Drug Major Business
Table 103. Global Blood Therapeutics Inc Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 104. Global Blood Therapeutics Inc SWOT Analysis
Table 105. Global Blood Therapeutics Inc Sickle Cell Disease Drug Product and Services
Table 106. Global Blood Therapeutics Inc Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 107. Genethon SA Sickle Cell Disease Drug Type and Application
Table 108. Genethon SA Sickle Cell Disease Drug Major Business
Table 109. Genethon SA Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 110. Genethon SA SWOT Analysis
Table 111. Genethon SA Sickle Cell Disease Drug Product and Services
Table 112. Genethon SA Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 113. Daiichi Sankyo Co Ltd Basic Information, Manufacturing Base and Competitors
Table 114. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Major Business
Table 115. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Total Revenue (USD Million) (2018-2019)
Table 116. Daiichi Sankyo Co Ltd SWOT Analysis
Table 117. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Product and Services
Table 118. Daiichi Sankyo Co Ltd Sickle Cell Disease Drug Sales (K Pcs), Price (USD/Pcs), Revenue, Gross Margin and Market Share (2018-2019)
Table 119. Global Sickle Cell Disease Drug Sales by Manufacturer (2018-2019) (K Pcs)
Table 120. Global Sickle Cell Disease Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 121. Key Players Sickle Cell Disease Drug Sales in Japan (2018-2019) (K Pcs)
Table 122. Key Players Sickle Cell Disease Drug Sales Market Share in Japan (2018-2019)
Table 123. Key Players Revenue of Sickle Cell Disease Drug in Japan (2018-2019) (USD Million)
Table 124. Global Sickle Cell Disease Drug Sales by Regions (2015-2020) (K Pcs)
Table 125. Global Sickle Cell Disease Drug Sales Market Share by Regions (2015-2020)
Table 126. Global Sickle Cell Disease Drug Revenue by Regions (2015-2020) (USD Million)
Table 127. Global Sickle Cell Disease Drug Sales and Forecast by Regions (2020-2025) (K Pcs)
Table 128. Global Sickle Cell Disease Drug Sales Market Share by Regions (2020-2025)
Table 129. Global Sickle Cell Disease Drug Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 130. Global Sickle Cell Disease Drug Revenue Market Share by Regions (2020-2025) (USD Million)
Table 131. North America Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 132. North America Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 133. North America Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 134. North America Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 135. North America Sickle Cell Disease Drug Sales by Country (2020-2025) (K Pcs)
Table 136. North America Sickle Cell Disease Drug Sales Market Share by Country (2020-2025)
Table 137. North America Sickle Cell Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 138. North America Sickle Cell Disease Drug Revenue Market Share by Country (2020-2025)
Table 139. Europe Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 140. Europe Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 141. Europe Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 142. Europe Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 143. Europe Sickle Cell Disease Drug Sales by Country (2020-2025) (K Pcs)
Table 144. Europe Sickle Cell Disease Drug Sales Market Share by Country (2020-2025)
Table 145. Europe Sickle Cell Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 146. Europe Sickle Cell Disease Drug Revenue Market Share by Country (2020-2025)
Table 147. Asia-Pacific Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 148. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 149. Asia-Pacific Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 150. Asia-Pacific Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 151. Asia-Pacific Sickle Cell Disease Drug Sales by Country (2020-2025) (K Pcs)
Table 152. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Country (2020-2025)
Table 153. Asia-Pacific Sickle Cell Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 154. Asia-Pacific Sickle Cell Disease Drug Revenue Market Share by Country (2020-2025)
Table 155. South America Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 156. South America Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 157. South America Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 158. South America Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 159. South America Sickle Cell Disease Drug Sales by Country (2020-2025) (K Pcs)
Table 160. South America Sickle Cell Disease Drug Sales Market Share by Country (2020-2025)
Table 161. South America Sickle Cell Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 162. South America Sickle Cell Disease Drug Revenue Market Share by Country (2020-2025)
Table 163. Middle East & Africa Sickle Cell Disease Drug Sales by Countries (2015-2020) (K Pcs)
Table 164. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Countries (2015-2020)
Table 165. Middle East & Africa Sickle Cell Disease Drug Revenue by Countries (2015-2020) (USD Million)
Table 166. Middle East & Africa Sickle Cell Disease Drug Revenue Market Share by Countries (2015-2020)
Table 167. Middle East & Africa Sickle Cell Disease Drug Sales by Country (2020-2025) (K Pcs)
Table 168. Middle East & Africa Sickle Cell Disease Drug Sales Market Share by Country (2020-2025)
Table 169. Middle East & Africa Sickle Cell Disease Drug Revenue by Country (2020-2025) (USD Million)
Table 170. Middle East & Africa Sickle Cell Disease Drug Revenue Market Share by Country (2020-2025)
Table 171. Japan Sickle Cell Disease Drug Sales by Type (2015-2020) (K Pcs)
Table 172. Japan Sickle Cell Disease Drug Sales Market Share by Type (2015-2020)
Table 173. Japan Sickle Cell Disease Drug Revenue by Type (2015-2020) (USD Million)
Table 174. Japan Sickle Cell Disease Drug Revenue Market Share by Type (2015-2020)
Table 175. Japan Sickle Cell Disease Drug Sales by Type (2020-2025) (K Pcs)
Table 176. Japan Sickle Cell Disease Drug Sales Market Share by Type (2020-2025)
Table 177. Japan Sickle Cell Disease Drug Revenue by Type (2020-2025) (USD Million)
Table 178. Japan Sickle Cell Disease Drug Revenue Market Share by Type (2020-2025)
Table 179. Global Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 180. Global Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 181. Global Sickle Cell Disease Drug Revenue by Application (2015-2020) (USD Million)
Table 182. Global Sickle Cell Disease Drug Revenue Market Share by Application (2015-2020)
Table 183. Global Sickle Cell Disease Drug Price by Application (2015-2020) (USD/Pcs)
Table 184. Global Sickle Cell Disease Drug Sales by Application (2020-2025) (K Pcs)
Table 185. Global Sickle Cell Disease Drug Sales Market Share by Application (2020-2025)
Table 186. Global Sickle Cell Disease Drug Revenue by Application (2020-2025) (USD Million)
Table 187. Global Sickle Cell Disease Drug Revenue Market Share by Application (2020-2025)
Table 188. Global Sickle Cell Disease Drug Price by Application (2020-2025) (USD/Pcs)
Table 189. Japan Sickle Cell Disease Drug Sales by Application (2015-2020) (K Pcs)
Table 190. Japan Sickle Cell Disease Drug Sales Market Share by Application (2015-2020)
Table 191. Japan Sickle Cell Disease Drug Revenue by Application (2015-2020) (USD Million)
Table 192. Japan Sickle Cell Disease Drug Revenue Market Share by Application (2015-2020)
Table 193. Japan Sickle Cell Disease Drug Sales by Application (2020-2025) (K Pcs)
Table 194. Japan Sickle Cell Disease Drug Sales Market Share by Application (2020-2025)
Table 195. Japan Sickle Cell Disease Drug Revenue by Application (2020-2025) (USD Million)
Table 196. Japan Sickle Cell Disease Drug Revenue Market Share by Application (2020-2025)
Table 197. Direct Channel Pros & Cons
Table 198. Indirect Channel Pros & Cons
Table 199. Distributors/Traders/ Dealers List
Table 200. Customers of Sickle Cell Disease Drug
Table 201. Market Opportunities in Next Few Years
Table 202. Market Risks Analysis
Table 203. Market Drivers
List of Figures
Figure 1. Sickle Cell Disease Drug Picture
Figure 2. Global Sickle Cell Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. ARQ-092 Picture
Figure 4. BIVV-003 Picture
Figure 5. CAL-H Picture
Figure 6. CTX-001 Picture
Figure 7. DRX-194 Picture
Figure 8. Others Picture
Figure 9. Sickle Cell Disease Drug Sales Market Share by Application in 2019
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Others Picture
Figure 13. Global Sickle Cell Disease Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 14. Global Sickle Cell Disease Drug Sales Growth Rate (2015-2025) (K Pcs)
Figure 15. Global Sickle Cell Disease Drug Sales Market Share by Manufacturer in 2019
Figure 16. Global Sickle Cell Disease Drug Revenue Market Share by Manufacturer in 2019
Figure 17. Key Players Sickle Cell Disease Drug Revenue Market Share in Japan in 2019
Figure 18. Global Top 5 Sickle Cell Disease Drug Manufacturer Market Share in 2019
Figure 19. Top 3 Sickle Cell Disease Drug Players Market Share in Japan in 2019
Figure 20. Global Sickle Cell Disease Drug Revenue Market Share by Regions in 2019
Figure 21. North America Sickle Cell Disease Drug Sales YoY Growth (2015-2025) (K Pcs)
Figure 22. North America Sickle Cell Disease Drug Revenue YoY Growth (2015-2025) (USD Million)
Figure 23. Europe Sickle Cell Disease Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 24. Europe Sickle Cell Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Asia-Pacific Sickle Cell Disease Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 26. Asia-Pacific Sickle Cell Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. South America Sickle Cell Disease Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 28. South America Sickle Cell Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 29. Middle East & Africa Sickle Cell Disease Drug Sales YoY Growth (2015-2020) (K Pcs)
Figure 30. Middle East & Africa Sickle Cell Disease Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 31. North America Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 32. North America Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 33. United States Sickle Cell Disease Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 34. Canada Sickle Cell Disease Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 35. Mexico Sickle Cell Disease Drug Market Size and Growth Rate (2015-2020) (USD Million)
Figure 36. Europe Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 37. Germany Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. United Kingdom Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 39. France Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 40. Russia Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Italy Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Asia-Pacific Sickle Cell Disease Drug Sales Market Share by Region 2018
Figure 43. Asia-Pacific Sickle Cell Disease Drug Revenue Market Share by Region 2018
Figure 44. China Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Japan Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. Korea Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 47. India Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 48. Southeast Asia Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Australia Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. South America Sickle Cell Disease Drug Sales Market Share by Country in 2019
Figure 51. South America Sickle Cell Disease Drug Revenue Market Share by Country in 2019
Figure 52. Brazil Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. Argentina Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Saudi Arabia Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 55. Turkey Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 56. Egypt Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 57. South Africa Sickle Cell Disease Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 58. Global Revenue Market Share of Sickle Cell Disease Drug by Type in 2019
Figure 59. Global Revenue Market Share of Sickle Cell Disease Drug by Application in 2019
Figure 60. Sales Channel: Direct Channel vs Indirect Channel